GSK Malaria Vaccine Gets Landmark Clearance For Use In Africa
WHO Recommendation Takes Account Of 2015 EMA Scientific Opinion
Executive Summary
Mosquirix is set for much wider availability in sub-Saharan Africa thanks to positive results from a pilot program in Ghana, Kenya and Malawi. The next step is deciding how to fund the vaccine’s rollout over the coming years.
You may also be interested in...
World's first malaria vaccine clears EMA hurdle
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended for approval the world's first vaccine for malaria1,2.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.